• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Aspire IRB, Midlands IRB join WIRB-Copernicus Group

Aspire IRB, Midlands IRB join WIRB-Copernicus Group

June 16, 2014
CenterWatch Staff

Aspire IRB and Midlands IRB have joined the WIRB-Copernicus Group (WCG), a provider of regulatory and ethical review services for clinical research.

Aspire IRB, located near San Diego, Calif., and Kansas City, Mo.-based Midlands IRB expand WCG’s presence in two major clinical research hubs and increase its expertise in early phase (phase I and II) reviews.

“We are delighted to welcome Midlands and Aspire to our family; these two high-quality organizations bring with them exceptional people, outstanding regulatory and compliance records and strong client relationships,” said Donald A. Deieso, Ph.D., WCG’s chairman and CEO. “Both Midlands and Aspire will continue to operate independently and will retain their leadership, personnel and brands.”

Midlands IRB and Aspire IRB will have access to WCG’s resources, including state-of-the-art technology, advisory panels and rigorous quality management and compliance programs.

“We are thrilled to bring to bear all of the resources of the WIRB-Copernicus Group to ensure the highest standards of human subject protection for our clients,” said Michele R. Baptista, CIP, president of Aspire IRB. “Not only will we continue to provide the hands-on, personalized interaction our clients have come to expect—and is so necessary in early phase research—but we will also be able to offer them more advanced technologies and services to facilitate the optimization of late phase (III & IV) research, such as electronic informed consent, learning management and accelerated study start-up solutions.”

The WCG family of companies now includes 12 individual AAHRPP-accredited panels, three of which are focused on the review of oncology research.

Financial details were not disclosed.

Upcoming Events

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • TechInnovation-360x240.png

    Pace of Technology Innovation in Trials Could Slow After Pandemic Eases

  • AskTheExperts-360x240.png

    Ask the Experts: Certifying and Maintaining Copies of Original Source Documents

  • Resources-360x240.png

    Trial Complexity, Endpoints Continue to Increase, Stretching Site Resources

  • FocusinRed-360x240.png

    Return to Focus on Risk Management Postpandemic Could Prove Challenging to Sites

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing